We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Bayer Limited

The Atrium, Blackthorn Road, Dublin 18,
Telephone: +353 1 2999 313
Fax: +353 1 2061 456
Patient Information Leaflet last updated on medicines.ie: 12/08/2016
PIL Adalat Retard 10 mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 12/08/2016 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 11/07/2016 and displayed until 12/08/2016
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 09/01/2015 and displayed until 11/07/2016
Reasons for adding or updating:
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 25/02/2014 and displayed until 09/01/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 20/06/2012 and displayed until 25/02/2014
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 17/05/2012 and displayed until 20/06/2012
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 07/10/2011 and displayed until 17/05/2012
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 05/10/2009 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 26/01/2009 and displayed until 05/10/2009
Reasons for adding or updating:
  • Change to marketing authorisation holder
  • Change to date of revision
Updated on 11/12/2008 and displayed until 26/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 29/09/2008 and displayed until 11/12/2008
Reasons for adding or updating:
  • Change of trade or active ingredient name
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 31/08/2006 and displayed until 29/09/2008
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to date of revision
Updated on 29/07/2005 and displayed until 31/08/2006
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 03/11/2004 and displayed until 29/07/2005
Reasons for adding or updating:
  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 28/07/2004 and displayed until 03/11/2004
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Nifedipine